Golden Biotechnology Corporation (TPEX:4132)
4.130
-2.370 (-36.46%)
Mar 26, 2026, 2:00 PM CST
-72.65% (1Y)
| Market Cap | 689.46M -73.2% |
| Revenue (ttm) | 44.58M -22.5% |
| Net Income | -314.93M |
| EPS | -1.96 |
| Shares Out | 162.23M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 17,778,168 |
| Average Volume | 3,236,126 |
| Open | 6.250 |
| Previous Close | 6.500 |
| Day's Range | 3.850 - 6.500 |
| 52-Week Range | 4.010 - 36.300 |
| Beta | 0.46 |
| RSI | 14.73 |
| Earnings Date | Apr 27, 2026 |